Economics and Value Proposition for Medical Device in the U.S.

Health Economics Evaluation and Value Proposition for an Antimicrobial Medical Device in the U.S. Market

Publications
Published on:
April 20, 2021
Written by:
Deepak Sahu

A health economics evaluation assists companies during product development to better understand the product’s impact across the ecosystem and position it appropriately.

Learn how Alira Health’s Global Market Access, Regulatory, and Clinical practices partnered with a client to fine-tune their market access strategy.

Deepak Sahu

To learn more about Alira Health’s work across the product development lifecycle, contact Deepak Sahu.

To learn more about Alira Health's market access strategy

Contact us

Related news

Events February 20, 2024
World EPA Congress Europe
Look for market access and pricing experts Ahmad Bechara and Andrea Mantovani representing Alira Health on the agenda at World EPA Congress.
Market Access Pricing Real-World Evidence (RWE)
News January 24, 2024
Alira Health and AseBio Announce Market Access Mentoring Program for 2024
Alira Health and AseBio, the Spanish Bioindustry Association, are pleased to announce the 2024 edition of their market access mentoring program for AseBio members.
Biotech Market Access Spain Startups
Case Studies January 18, 2024
Pharma Company Succeeds in Adding Medicine to World Health Organization Essential Medicines List
A pharma company with a blood disorder treatment needed support to submit a value dossier to the WHO to add a medicine to the Essential Medicines List.
Market Access Pharma
News January 18, 2024
Alira Health and Biocat Announce Startup Support Program for 2024
Alira Health and Biocat, a strategic stakeholder building the Catalan life sciences and ecosystem, partnered to foster Market Access for startups.
Market Access Startups
Events January 17, 2024
Presentation: Pilot Project for the Inclusion of the Patient Voices in the Regional Market Access Drug Committees in Spain
On January 23rd we will present the results of the first phase of the “Pilot Project for the Inclusion of the Patient Voices in the Regional Market Access Drug Committees in Spain.”
Market Access Patient Engagement Spain
Case Studies January 8, 2024
Pharma Company Extends to New Markets through Strategic Licensing Agreements
A Swedish pharma company saw a market opportunity to expand access to its proprietary product outside of the Nordics and sought support developing strategic licensing deals.
Market Access Pharma
Publications December 21, 2023
Everything You Need to Know About Market Access in China
Our market access experts have outlined the healthcare system and key market access pathways that are opening in China for pharmaceutical products, including vaccines.
Market Access
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.